Ausgabe 8/2023
Inhalt (11 Artikel)
Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice
Fausto Alfredo Rios-Olais, Talal Hilal
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma
Simon Wu, Piers Blombery, David Westerman, Constantine S. Tam
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions
Robert Stuver, Steven M. Horwitz, Zachary D. Epstein-Peterson
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer
Katleen Janssens, Chinouk Lambrechts, Barbara Geerinckx, Ken Op de Beeck, Guy Van Camp, Helena Oliveres, Hans Prenen, Timon Vandamme, Marc Peeters
Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies
Jennifer Kahan, Constanza Martinez, Christina Tsien
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?
Julia Dixon-Douglas, Sherene Loi
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
Yan Xiao, Bingbing Hu, Yao Guo, Dengyang Zhang, Yuming Zhao, Yun Chen, Na Li, Liuting Yu
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia
Alexandra Rezazadeh, Michael Deininger, Ehab Atallah
Cardio-oncology for Pediatric and Adolescent/Young Adult Patients
Drishti Tolani, Julia Wilcox, Sharvari Shyam, Neha Bansal
Interventional Cardio-Oncology: Unique Challenges and Considerations in a High-Risk Population
Orly Leiva, Usman Alam, Isaac Bohart, Eric H. Yang
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming
Lisa Miller-Phillips, Eric A. Collisson